|
PPT1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.857600E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.702800E-01 |
| Normal-vs-Stage2 |
3.778300E-02 |
| Normal-vs-Stage3 |
5.312400E-01 |
| Normal-vs-Stage4 |
1.566820E-01 |
| Stage1-vs-Stage2 |
1.776970E-01 |
| Stage1-vs-Stage3 |
9.084000E-01 |
| Stage1-vs-Stage4 |
1.724170E-01 |
| Stage2-vs-Stage3 |
1.650960E-01 |
| Stage2-vs-Stage4 |
7.356000E-01 |
| Stage3-vs-Stage4 |
1.725040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.769770E-01 |
| Normal-vs-AfricanAmerican |
4.179800E-03 |
| Normal-vs-Asian |
4.668200E-01 |
| Caucasian-vs-AfricanAmerican |
5.270000E-02 |
| Caucasian-vs-Asian |
4.581400E-01 |
| AfricanAmerican-vs-Asian |
9.366600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.887410E-01 |
| Normal-vs-Female |
4.737700E-03 |
| Male-vs-Female |
2.747900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.735430E-01 |
| Normal-vs-Extreme_Weight |
1.837200E-01 |
| Normal-vs-Obese |
2.654000E-01 |
| Normal-vs-Extreme_Obese |
4.314600E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.058400E-01 |
| Normal_Weight-vs-Obese |
6.544800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.772840E-01 |
| Extreme_Weight-vs-Obese |
9.115000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.786950E-01 |
| Obese-vs-Extreme_Obese |
1.994220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.647600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.501800E-02 |
| Normal-vs-Age(61-80Yrs) |
2.271200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.625650E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.204600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.522000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.466600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.544400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.881000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.151600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.186200E-01 |
| Normal-VS-Type2 PRCC |
1.729030E-01 |
| Normal-VS-KIRP CIMP |
1.853960E-01 |
| Normal-VS-Unclassified PRCC |
1.156060E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.962800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.331000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.639500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.811400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.412800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.931000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.959800E-01 |
| Normal-vs-N1 |
1.647800E-01 |
| Normal-vs-N2 |
4.016000E-01 |
| N0-vs-N1 |
3.881800E-01 |
| N0-vs-N2 |
2.370600E-01 |
| N1-vs-N2 |
4.900600E-01 |
|
|
